tiprankstipranks
Advertisement
Advertisement

ESPR Stock Latest News

Is ESPR a Buy, Before Earnings?
Pre-EarningsIs ESPR a Buy, Before Earnings?
13d ago
ESPR
Esperion acquired in cash-and-CVR merger transaction
PremiumCompany Announcements
Esperion acquired in cash-and-CVR merger transaction
1M ago
8K
ESPR
Esperion shareholders approve merger with Essence Parent Inc.
PremiumCompany Announcements
Esperion shareholders approve merger with Essence Parent Inc.
1M ago
8K
ESPR
Esperion clears key U.S. antitrust hurdle for merger
PremiumCompany Announcements
Esperion clears key U.S. antitrust hurdle for merger
2M ago
8K
ESPR
Esperion Gains German Approval for ArchiMed Acquisition Deal
PremiumCompany Announcements
Esperion Gains German Approval for ArchiMed Acquisition Deal
2M ago
8K
ESPR
Esperion Shareholders Approve Directors, Pay, and Equity Plan
PremiumCompany AnnouncementsEsperion Shareholders Approve Directors, Pay, and Equity Plan
2M ago
8K
ESPR
Esperion presents new data from CLEAR Outcomes, CLEAR Phase 2 study
Premium
The Fly
Esperion presents new data from CLEAR Outcomes, CLEAR Phase 2 study
3M ago
ESPR
Esperion Therapeutics’ 10-Q Forward-Looking Statements Highlight Significant Uncertainty and Investor Risk
Premium
Company Announcements
Esperion Therapeutics’ 10-Q Forward-Looking Statements Highlight Significant Uncertainty and Investor Risk
3M ago
ESPR
EXE, IP, ESPR, CMPS, TNXP Trending With Analysts
PremiumWeekend Updates
EXE, IP, ESPR, CMPS, TNXP Trending With Analysts
3M ago
IP
EXE
ESPR Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ESPR Earnings this Week: How Will it Perform?
3M ago
ESPR
Esperion downgraded to Hold from Buy at Needham
PremiumThe Fly
Esperion downgraded to Hold from Buy at Needham
3M ago
ESPR
AI Models Turn More Positive on Esperion as ARCHIMED Buyout Drives Upside
PremiumAI Analyst Ratings
AI Models Turn More Positive on Esperion as ARCHIMED Buyout Drives Upside
3M ago
ESPR
Esperion Stock Surges Onto Analysts’ Trending Radar
PremiumWeekend UpdatesEsperion Stock Surges Onto Analysts’ Trending Radar
4M ago
ESPR
Esperion downgraded to Hold from Buy at Jefferies
Premium
The Fly
Esperion downgraded to Hold from Buy at Jefferies
4M ago
ESPR
Esperion downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
Esperion downgraded to Neutral from Overweight at Piper Sandler
4M ago
ESPR
Esperion agrees to $1.1 billion ARCHIMED buyout
PremiumCompany Announcements
Esperion agrees to $1.1 billion ARCHIMED buyout
4M ago
8K
ESPR
Midday Fly By: Apple reports Q2 beat, oil majors post mixed results
PremiumThe Fly
Midday Fly By: Apple reports Q2 beat, oil majors post mixed results
4M ago
AN
BP
Esperion downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Esperion downgraded to Neutral from Buy at H.C. Wainwright
4M ago
ESPR
Esperion downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe Fly
Esperion downgraded to Neutral from Overweight at Cantor Fitzgerald
4M ago
ESPR
Esperion to be acquired by Archimed for $3.16 per share, one CVR
PremiumThe FlyEsperion to be acquired by Archimed for $3.16 per share, one CVR
4M ago
ESPR
Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
Premium
Ratings
Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
4M ago
ESPR
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
Premium
Company Announcements
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
4M ago
8K
ESPR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >